Influence of Vitamin D Deficiency on Rheumatoid Arthritis Course
DOI:
https://doi.org/10.22141/2224-1507.3.23.2016.85001Keywords:
rheumatoid arthritis, disease activity, vitamin D deficiencyAbstract
The article deals with the influence of vitamin D deficiency on the course of rheumatoid arthritis. It encloses the review and the results of own researches. It was found that 54.9 % of the patients with rheumatoid arthritis had vitamin D deficiency, and 37.6 % — insufficiency. Serum 25(OH)D level was significantly lower in patients with the rheumatoid arthritis of III grade compared with the patients with the minimal activity (16.55 ± 9.26 vs 22.59 ± 9.74 ng/ml, p < 0.05). There was determined the correlation between serum 25(OH)D level and disease activity parameters: ESR (r = –0.26; p < 0.05), DAS28-ESR (r = –0.36; p < 0.001), and CRP (r = –0.24; p < 0.05). Vitamin D deficiency can be an important factor for worsening of rheumatoid arthritis. The effect of vitamin D supplementation in the complex therapy is needed to determine if a causal relationship exists.
References
Alele J.D. The importance of inflammation and vitamin D status in SLE-associated osteoporosis / J.D. Alele, D.L. Kamen // Autoimmun. Rev. — 2010. — Vol. 9. — Р. 137-139.
Holick M.F. Vitamin D: importance in the prevention of cancers, type 1 diabetes, heart disease, and osteoporosis / M.F. Holick // Am. J. Clin. Nutr. — 2004. — Vol. 79. — Р. 362-371.
Cutolo M. Vitamin D endocrine system involvement in autoimmune rheumatic diseases / M. Cutolo, C. Pizzorni, A. Sulli // Autoimmun. Rev. — 2011. — Vol. 11. — Р. 84-87.
Arnson Y. Vitamin D and autoimmunity: new aetiological and therapeutic considerations / Y. Arnson, H. Amital, Y. Shoen-feld // Ann. Rheum. Dis. — 2007. — Vol. 66. — Р. 1137-1142.
Effects of vitamin D on the peripheral adaptive immune system: a review / E. Peelen, S. Knippenberg, A.H. Muris [et al.] // Autoimmun. Rev. — 2011. — Vol. 10. — Р. 733-743.
Suppressive effect of 1alpha, 25-dihydroxyvitamin D3 ontype I IFN-mediated monocyte differentiation into dendritic cells: impairment of functional activities and chemotaxis / M.C. Gauzzi, C. Purificato, K. Donato [et al.] // J. Immunol. — 2005. — Vol. 174. — Р. 270-276.
1alpha, 25-Dihydroxyvitamin d3 has a direct effect on naive CD4(+) T cellstoenhance the development of Th2 cells / A. Boonstra, F.J. Barrat, C. Crain [etal.] // J. Immunol. — 2001. — Vol. 167. — Р. 4974-4980.
van Etten E. Immunoregulation by 1,25-dihydroxyvitamin D3: basic concepts / E. van Etten, C. Mathieu // J. Steroid. Biochem. Mol. Biol. — 2005. — Vol. 97. — Р. 93-101.
Treatment of experimental autoimmune prostatitis in nonobese diabetic mice by the vitamin D receptor agonist elocalcitol / G. Penna, S. Amuchastegui, C. Cossetti [et al.] // J. Immunol. — 2006. — Vol. 177. — Р. 8504-8511.
Chen S., Sims G.P., Chen X.X., Gu Y.Y., Chen S., Lipsky P.E. Modulatory effects of 1,25-dihydroxyvitamin D3 on human B cell differentiation // J. Immunol. — 2007. — Vol. 179. — Р. 1634-1647.
Adorini L. Dendritic cell tolerogenicity: a key mechanism in immunomodulation by vitamin D receptor agonists / L. Adorini, G. Penna // Hum. Immunol. — 2009. — Vol. 70. — Р. 345-352.
Gatenby P. Vitamin D deficiency and risk for rheumatic diseases: an update / P. Gatenby, R. Lucas, A. Swaminathan // Curr. Opin. Rheumatol. — 2013. — Vol. 25, № 2. — P. 184-191.
Harris E.D. Jr. Rheumatoid arthritis. Pathophysiology and implications for therapy / E.D. Jr. Harris // N. Engl. J. Med. — 1990. — Vol. 322. — P. 1277-1289.
Induction of macrophage migration inhibitory factor in ConA-stimulated rheumatoid arthritis synovial fibroblasts through the P38 map kinase dependent signaling pathway / H.R. Kim, M.K. Park, M.L. Cho [et al.] // Korean J. Intern. Med. — 2010. — Vol. 25. — P. 317-326.
Low vitamin D levels in outpatient postmenopausal women from a rheumatology clinic in Madrid, Spain: their relationship with bone mineral density / P. Aguado, M.T. del Campo, M.V. Garces [et al.] // Osteoporosis Int. — 2001. — Vol. 11. — P. 739-744.
Vitamin D and rheumatoid arthritis / I. Kostoglou-Athanassiou, P. Athanassiou, A. Lyraki, I. Raftakis, C. Antoniadis // Ther. Adv. Endocrinol. Metab. – 2012. — Vol. 3. № 6. — P. 181-187.
Als O.S. Serum concentration of vitamin D metabolites in rheumatoid arthritis / O.S. Als, B. Rils, C. Christiansen // Clin. Rheumatol. — 1987. — Vol. 6. — P. 238-243.
Vitamin D is associated with lower risk of rheumatoid arthritis in older women: results from the Iowa Women’s Health Study / L.A. Merlino, J. Curtis, T.R. Mikuls [et al.] // Arthritis Rheum. — 2004. — Vol. 50. — P. 72-77.
Vitamin D intake and risks of systemic lupus erythematosus and rheumatoid arthritis in women / K.H. Costenbader, D. Feskanich, M. Holmes [et al.] // Ann. Rheum. Dis. — 2008. — Vol. 67. — P. 530-535.
Vitamin D deficiency does not increase the risk of rheumatoid arthritis: comment on the article by Merlino / M.M. Nielen., D. van Schaardenburg, W.F Lems [et al.] // Arthritis Rheum. — 2006. — Vol. 54. — P. 3719-3720.
Leventis P. Clinical aspects of vitamin D in the management of rheumatoid arthritis / P. Leventis, S. Patel // Rheumatology. — 2008. — Vol. 47. — P. 1617-1621.
Kroger H. Low serum vitamin D metabolites in women with rheumatoid arthritis / H. Kroger, I.M. Pentilla, E.M. Alhava // Scand. J. Rheumatol. — 1993. — Vol. 22. — P. 172-177.
Vitamin D and rheumatoid arthritis: comment on the letter by Nielen et al. / M. Cutolo, K. Otsa, M. Yprus [et al.] // Arthritis Rheum. — 2007. — Vol. 56. — P. 1719-1720.
Haque U.J. Relationships among vitamin D, diseaseactivity, pain and disability in rheumatoid arthritis / U.J. Haque, S.J. Bartlett // Clin. Exp. Rheumatol. — 2010. — Vol. 28. — P. 745-747.
Song G.G. Association between vitamin D intake and the risk of rheumatoid arthritis: a meta-analysis / Gwan Gyu Song, Sang-Cheol Bae, Young Ho Lee // Clin. Rheumatol. — 2012. — Vol. 31. — P. 1733-1739.
Наказ № 263 від 11.04.2014 «Про затвердження Уніфікованого клінічного протоколу первинної, вторинної (спеціалізованої), третинної (високоспеціалізованої) медичної допомоги та медичної реабілітації «Ревматоїдний артрит».
Наказ № 263 від 11.04.2014 «Про затвердження адаптованої клінічної настанови, заснованої на доказах, «Ревматоїдний артрит».
Aletaha D., Ward M.M., Machold K.P. et al. Remission and active disease in rheumatoid arthritis: defining criteria for disease activity states // Arthritis and Rheumatism. — 2005. — 52 (9). — 2625-2636.
The DAS28 Score. National Rheumatoid Arthritis Society. Available online: http://www.nras.org.uk/about_rheumatoid_arthritis/established_disease/managing_well/the_das28_score.aspx (accessed on 11 September 2011).
Holick M.F., Binkley N.C., Bischoff-Ferrari H.A. et al. Evaluation, treatment, and prevention of vitamin D deficiency: anedrocrine society clinical practice // J. Clin. Endocrinol. Metab. — 011. — 96 (7). — 191-193.
Downloads
Issue
Section
License
Copyright (c) 2020 PAIN, JOINTS, SPINE
This work is licensed under a Creative Commons Attribution 4.0 International License.
Our edition uses the copyright terms of Creative Commons for open access journals.
Authors, who are published in this journal, agree with the following terms:
- The authors retain rights for authorship of their article and grant to the edition the right of first publication of the article on a Creative Commons Attribution 4.0 International License, which allows others to freely distribute the published article, with the obligatory reference to the authors of original works and original publication in this journal.
- Directing the article for the publication to the editorial board (publisher), the author agrees with transmitting of rights for the protection and using the article, including parts of the article, which are protected by the copyrights, such as the author’s photo, pictures, charts, tables, etc., including the reproduction in the media and the Internet; for distributing; for the translation of the manuscript in all languages; for export and import of the publications copies of the writers’ article to spread, bringing to the general information.
- The rights mentioned above authors transfer to the edition (publisher) for the unlimited period of validity and on the territory of all countries of the world.
- The authors guarantee that they have exclusive rights for using of the article, which they have sent to the edition (publisher). The edition (the publisher) is not responsible for the violation of given guarantees by the authors to the third parties.
- The authors have the right to conclude separate supplement agreements that relate to non-exclusive distribution of their article in the form in which it had been published in the journal (for example, to upload the work to the online storage of the journal or publish it as part of a monograph), provided that the reference to the first publication of the work in this journal is included.
- The policy of the journal permits and encourages the publication of the article in the Internet (in institutional repository or on a personal website) by the authors, because it contributes to productive scientific discussion and a positive effect on efficiency and dynamics of the citation of the article.
